Search for: "Genentech" Results 1 - 20 of 899
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Dec 2022, 3:15 pm by Lawrence B. Ebert
The outcome: Genentech, Inc. and InterMune, Inc. [read post]
15 May 2016, 7:04 pm by Consuella Pachico
Comanche County Memorial Hospital said San Francisco-based Genentech shortchanged hospitals by putting less Herceptin in the bottleThe post Genentech Inc., Sued For Cheating Providers appeared first on Legal Reader. [read post]
13 Aug 2008, 3:03 pm
In rebuffing Roche’s $89-per-share offer for the 44 percent of Genentech it doesn’t already own, [...] [read post]
12 Jun 2008, 7:00 am
On June 11, Genentech announced it had settled with MedImmune concerning the dispute over the Cabilly patent.Marilyn Chase of the WSJ reported: The settlement dismisses MedImmune's challenge of the patent, under which it pays royalties to Genentech on sales of its product Synagis, which is used to prevent respiratory infection in infants. [read post]
Genentech’s Unique Approach to D&I Highsmith distinguishes Genentech’s DEI efforts by emphasizing their integration into the business. [read post]
Genentech’s Unique Approach to D&I Highsmith distinguishes Genentech’s DEI efforts by emphasizing their integration into the business. [read post]
21 Jul 2008, 1:50 pm
Will Roche need to dig deeper to win Genentech? [read post]
19 Jun 2016, 5:49 pm by Consuella Pachico
Specifically, the feds contend that between 2006 and 2011, the companies gave promotional materials to oncologists which included misleading andThe post Genentech And OSI To Pay $67 Million To Resolve Charges appeared first on Legal Reader. [read post]
25 Jul 2008, 12:08 pm
" On Monday, Roche announced a bid of $89 a share for the 44 percent of Genentech stock it [...] [read post]
2 Aug 2007, 7:56 pm
Singer -- Genentech announced in an August 2, 2007 press release that the Hart-Scott-Rodino waiting period that applied to its acquisition of Tanox, Inc. has expired, and that the acquisition is now completed. [read post]
6 Mar 2009, 9:39 am
The Swiss drug giant Roche raised its hostile offer on Friday to buy out the biotechnology company Genentech to $93 a share, from $86.50. [read post]
11 Jan 2007, 3:27 pm
IPBiz notes that the Supreme Court case established the standing of MedImmune, a licensee paying its royalties, to file a DJ action against patentee Genentech. [read post]
1 Mar 2009, 9:43 pm
Noonan -- Genentech announced last week that the U.S. [read post]
30 Mar 2020, 9:08 pm by Patent Docs
Noonan -- The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) claim construction (and inter partes review (IPR) decision invalidating claims for obviousness) in it recent Genentech, Inc. v. [read post]